|
08 Jun 2007 |
Alkermes Announces Initiation of Phase I Clinical Study of AIR(R) Parathyroid Hormone
|
|
08 Jun 2007 |
Discovery Labs Initiates Phase 2 Clinical Trial in Children with Acute Respiratory Failure
|
|
08 Jun 2007 |
Human Genome sciences announces positive final results of Phase 2b trial of Albuferon(R)
|
|
08 Jun 2007 |
Lipid Sciences Announces Validation of Proprietary Peptide That Mimics Key Functions of Natural Human HDL
|
|
06 Jun 2007 |
Unigene Reports That Oral Calcitonin Phase III Clinical Study for Osteoarthritis Treatment is Initiated
|
|
05 Jun 2007 |
Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
|
|
05 Jun 2007 |
SciClone's SCV-07 Inhibits Melanoma Tumor Growth in Animal Model Study
|
|
05 Jun 2007 |
ONTAK(R) (denileukin diftitox) Achieves 49.1% Overall Response Rate in
|
|
04 Jun 2007 |
Xanthus announces Phase 1 results for P2045 - a targeted agent for nonsmall cell lung cancer
|
|
03 Jun 2007 |
Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
|
|
01 Jun 2007 |
Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
|
|
01 Jun 2007 |
Hemispherx Presents Potential Avian Influenza Treatment Breakthrough at Paris Conference
|
|
01 Jun 2007 |
Cytheris to start two phase I/IIa clinical trials of CYT107, its new recombinant Interleukin-7, in Hepatitis C and oncology
|
|
01 Jun 2007 |
Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex(TM) (ancrod)
|
|
01 Jun 2007 |
Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
|
|
01 Jun 2007 |
Top line results of phase III study in acute ischemic stroke (DIAS-2) do not demonstrate difference between desmoteplase and placebo
|
|
26 May 2007 |
Mircera receives positive opinion in Europe for the treatment of anaemia due to chronic kidney disease
|
|
26 May 2007 |
Tercica Reports Increlex Receives CHMP Positive Opinion for the Treatment of Severe Primary IGF-1 Deficiency
|
|
25 May 2007 |
Emisphere Announces Initiation of Phase III Clinical Program of Oral Calcitonin for the Treatment of Osteoarthritis
|
|
24 May 2007 |
Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association
|
|
24 May 2007 |
Northfield Laboratories Reports Results of Pivotal Phase III Trauma Study
|
|
23 May 2007 |
Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study
|
|
23 May 2007 |
Phase 1b insulin clinical trial commenced
|
|
23 May 2007 |
Voraxaze (TM) Update
|
|
22 May 2007 |
Roche receives approvable letter for Mircera in the United States
|
